Arcadia Biosciences (RKDA) has provided an announcement.
Arcadia Biosciences announced key executive changes, with Stanley Jacot resigning as president, CEO, and director, and the company agreeing to a hefty severance package including cash, stock option vesting, and health insurance coverage. Thomas J. Schaefer steps up as the new CEO, bringing a wealth of finance experience and a solid educational background. Mark Kawakami fills Schaefer’s former CFO role, equipped with a strong analytical background and diverse financial expertise.
Find detailed analytics on RKDA stock on TipRanks’ Stock Analysis page.
